This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He’s Buying Now.

• Druckenmiller produced 30% mean yearly returns with nary losing years astatine Duquesne from 1981 to 2010.

• Natera (NTRA) gross roseate 35% year-over-year successful Q3 2025 and bushed expert estimates by 14%.

• Insmed (INSM) banal surged from beneath $26 successful May 2024 to astir $200 with gross increasing 52% year-over-year successful Q3 2025.

• If you’re reasoning astir retiring oregon cognize idiosyncratic who is, determination are 3 speedy questions causing galore Americans to recognize they tin discontinue earlier than expected. instrumentality 5 minutes to larn much here

Stanley Druckenmiller has been 1 of the astir palmy investors, a billionaire with a agelong grounds of precocious returns successful planetary macro investing. He's present piling into Natera (NASDAQ:NTRA), Insmed (NASDAQ:INSM), and Teva Pharmaceutical (NYSE:TEVA). They're worthy looking into, arsenic Druckenmiller has an exceptional record.

In 1977, Druckenmiller started his fiscal vocation arsenic an lipid expert and absorption trainee astatine Pittsburgh National Bank.​

Within astir a year, helium roseate to go caput of the bank's equity probe group, an aboriginal motion of his analytical accomplishment and accelerated advancement.​

In 1981, helium near the slope to recovered his ain concern firm, Duquesne Capital Management, which would go the main conveyance for his investing career.​ Druckenmiller's estimation grew arsenic helium balanced moving Duquesne with consulting enactment for the Dreyfus Corporation. By 1986, helium was named caput of the Dreyfus Fund portion inactive managing Duquesne. Two years later, George Soros hired Druckenmiller arsenic the pb portfolio manager for the Quantum Fund and a cardinal manager astatine Soros Fund Management.

There, helium helped technologist the 1992 commercialized against the British pound, "breaking the Bank of England" and reportedly earning implicit $1 cardinal successful profit.

From 1981 to the fund's closing successful 2010, Druckenmiller produced mean yearly returns of astir 30% with nary losing years astatine Duquesne. He returned each extracurricular capitalist wealth and shifted to managing lone his ain luck thereafter. That doesn't mean each his trades are present secrets. You tin inactive get a glimpse of the stocks helium is buying done the Duquesne Family Office LLC.

Natera is simply a familial investigating company. It specializes successful utilizing cell-free DNA (cfDNA) to supply diagnostic tests similar non-invasive prenatal tests. NTRA banal has historically been rather volatile, but it has been connected a terrific tally since precocious 2023.

NTRA banal is up implicit 500% since its trough successful October 2023. This rally is lone accelerating with clip arsenic gross surpasses expert expectations. Revenue roseate 34.66% year-over-year successful Q3 2025 and bushed expert estimates by 13.9%. The 4th before, gross bushed estimates by 14.63%. Management besides accrued full-year guidance to $2.18 cardinal to $2.26 billion. This came aft a guidance summation successful Q2 2025 arsenic well. The archetypal Q1 guidance was $240 cardinal little astatine the midpoint.